SIMCERE PHARMA (02096) spent 10.1667 million Hong Kong dollars to repurchase 1.49 million shares on November 18th.
Sinopharm (02096) announced that on November 18, 2024, the company invested 1016.67 million...
SIMCERE PHARMA (02096) announced that on November 18, 2024, the company repurchased 1.49 million shares at a cost of 10.167 million Hong Kong dollars. The repurchase price was between 6.71 and 6.98 Hong Kong dollars per share.
Related Articles
New stock news | Jia Zhi Technology submits application to Hong Kong Stock Exchange as one of the top ten global intelligent mobile robot and automation company Siasun Robot & Automation.
New Stock News | Jia Zhi Technology Submits Application to Hong Kong Stock Exchange
New Stock Outlook | Increase in revenue without increase in profit signifies multiple challenges, with the largest customer revenue share of Cloud Intelligence exceeding 90% in 2024.
New stock news | Jia Zhi Technology submits application to Hong Kong Stock Exchange as one of the top ten global intelligent mobile robot and automation company Siasun Robot & Automation.
New Stock News | Jia Zhi Technology Submits Application to Hong Kong Stock Exchange
New Stock Outlook | Increase in revenue without increase in profit signifies multiple challenges, with the largest customer revenue share of Cloud Intelligence exceeding 90% in 2024.
RECOMMEND
Paul Chan Says Hong Kong Has Licensed 11 Virtual Asset Exchanges, Stablecoin Licenses Expected Later This Year
22/01/2026
Ministry Of Finance And Other Departments Introduce Comprehensive Fiscal And Financial Policies To Boost Domestic Demand
22/01/2026
Capital Migration: Five Years On, An In‑Depth Analysis Of China’s 11 High‑Growth Venture Capital Tracks In 2025
22/01/2026
